Endpoints News

How a 20-year old asthma drug is boosting food allergy research

Peanut bans at schools. EpiPen training at summer camps. Parents struggling to find an alternative to PB&J.

This report was first published by Endpoints News. To see the original version, click here

Peanut bans at schools. EpiPen training at summer camps. Parents struggling to find an alternative to PB&J.

The massive rise in food allergies transformed how many American children grow up. But a combination of better biological understanding, and a new use of an old drug, has opened up a potentially huge market in biopharma — and effective treatments for patients.

您已阅读5%(457字),剩余95%(8831字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×